Evidence map›Paper›PMID 35657290›Full record

ArticleJournal of neuroendocrinology2022

Altered PVN-to-CA2 hippocampal oxytocin pathway and reduced number of oxytocin-receptor expressing astrocytes in heart failure rats.

Ferdinand Althammer, Ranjan K Roy, Arthur Lefevre, Rami S Najjar, Kai Schoenig, Dusan Bartsch, Marina Eliava, Rafaela G Feresin, Elizabeth A D Hammock, Anne Z Murphy and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroendocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Ferdinand AlthammerCenter for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, Georgia, USA.
Ranjan K RoyCenter for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, Georgia, USA.
Arthur LefevreDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
Rami S NajjarDepartment of Nutrition, Georgia State University, Atlanta, Georgia, USA.
Kai SchoenigDepartment of Molecular Biology Central Institute of Mental Health, Mannheim, Germany.
Dusan BartschDepartment of Molecular Biology Central Institute of Mental Health, Mannheim, Germany.
Marina EliavaDepartment of Neuropeptide Research in Psychiatry, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.
Rafaela G FeresinDepartment of Nutrition, Georgia State University, Atlanta, Georgia, USA.
Elizabeth A D HammockDepartment of Psychology and Program in Neuroscience, The Florida State University, Tallahassee, Florida, USA.ORCID 0000-0001-7668-745X
Anne Z MurphyNeuroscience Institute, Georgia State University, Atlanta, Georgia, USA.
Alexandre CharletCentre National de la Recherche Scientifique and University of Strasbourg, Institute of Cellular and Integrative Neuroscience, Strasbourg, France.
Valery GrinevichCenter for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, Georgia, USA.
Javier E SternCenter for Neuroinflammation and Cardiometabolic Diseases, Georgia State University, Atlanta, Georgia, USA.
Georgia State University · USCentral Institute of Mental Health · DEHeidelberg University · DEFlorida State University · USInstitut des Neurosciences Cellulaires et Intégratives · FR

Funding

Altered CNS Intercellular Signaling Mechanisms in Cardiovascular DiseaseR01HL090948 · NHLBI · UNIVERSITY OF CINCINNATI · PI STERN, JAVIER E · 2008 to 2017
$3.0M
DENDRITIC RELEASE OF NEUROPEPTIDES: ROLE IN BODILY HOMEOSTASISR01NS094640 · NINDS · GEORGIA STATE UNIVERSITY · PI STERN, JAVIER E · 2016 to 2020
$1.4M
National Heart, Lung, and Blood Institute Grant NIH HL090948NHLBI NIH HHS R01 HL090948NINDS NIH HHS NIH NS094640NINDS NIH HHS R01 NS094640
6 · The paper itself

Abstract

Oxytocinergic actions within the hippocampal CA2 are important for neuromodulation, memory processing and social recognition. However, the source of the OTergic innervation, the cellular targets expressing the OT receptors (OTRs) and whether the PVN-to-CA2 OTergic system is altered during heart failure (HF), a condition recently associated with cognitive and mood decline, remains unknown. Using immunohistochemistry along with retrograde monosynaptic tracing, RNAscope and a novel OTR-Cre rat line, we show that the PVN (but not the supraoptic nucleus) is an important source of OTergic innervation to the CA2. These OTergic fibers were found in many instances in close apposition to OTR expressing cells within the CA2. Interestingly, while only a small proportion of neurons were found to express OTRs (~15%), this expression was much more abundant in CA2 astrocytes (~40%), an even higher proportion that was recently reported for astrocytes in the central amygdala. Using an established ischemic rat heart failure (HF) model, we found that HF resulted in robust changes in the PVN-to-CA2 OTergic system, both at the source and target levels. Within the PVN, we found an increased OT immunoreactivity, along with a diminished OTR expression in PVN neurons. Within the CA2 of HF rats, we observed a blunted OTergic innervation, along with a diminished OTR expression, which appeared to be restricted to CA2 astrocytes. Taken together, our studies highlight astrocytes as key cellular targets mediating OTergic PVN inputs to the CA2 hippocampal region. Moreover, they provide the first evidence for an altered PVN-to-CA2 OTergic system in HF rats, which could potentially contribute to previously reported cognitive and mood impairments in this animal model.

Indexed as

Heart FailureReceptors, OxytocinAnimalsAstrocytesHippocampusOxytocinParaventricular Hypothalamic NucleusRatsOxytocinReceptors, Oxytocinastrocytecardiovasculargliahippocampushypothalamusoxytocin

Identifiers

PMID35657290
PMCPMC9495289
OpenAlexW4280600305

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.